TXT In plain English
Company description
PFIZER LIMITED is a UK company whose Companies House status is “Active” and whose registered company type is “Private Limited Company”. Incorporated on 27 November 1953; registered for 72 years; registered office reported in KENT. Its primary declared activity is 46460 · Wholesale of pharmaceutical goods, with 1 additional SIC activity reported.
This BritDB profile also contains linked public records: 1 PSC record, 30 trade marks, 27 procurement records. This description is assembled from public data, is not a reliability assessment, and should be checked against the cited sources before a legally significant decision.
Web facts are never added from a name match alone. Internet enrichment requires the exact Companies House ID in Wikidata, and ambiguous results are excluded.
01 Company overview
Identity and registration
- Official name
- PFIZER LIMITED
- Company number
- 00526209
- Company type
- Private Limited Company
- Status
- Active
- Country of origin
- United Kingdom
- Dissolution date
- Not supplied
- Accounts category
- FULL
- Mortgage charges
- 0 total · 0 outstanding · 0 satisfied
- Limited partnership members
- 0 general · 0 limited
A registered office is not necessarily a trading location. The address is reproduced from the Companies House bulk record and should be interpreted in that legal context.
02 Filing dates
Accounts and statements
Last accounts made up to
30 November 2025Next accounts due
31 August 2027Last statement made up to
29 June 2026Next statement due
13 July 2027BritDB does not infer overdue status when the source does not state it.
03 Workforce reporting
Gender pay gap
- Median bonus gap
- 28.1%
- Mean bonus gap
- 24.2%
- Women receiving bonus
- 90.8%
- Men receiving bonus
- 94.4%
- Women in top quartile
- 43.2%
- Women in upper middle quartile
- 49.6%
- Women in lower middle quartile
- 62.0%
- Women in lower quartile
- 69.0%
Earlier reporting years (8)
- 1000 to 499913.8% median hourly gap
- 1000 to 499913.8% median hourly gap
- 1000 to 499917.4% median hourly gap
- 1000 to 499917.2% median hourly gap
- 1000 to 499917.7% median hourly gap
- 1000 to 499926.0% median hourly gap
- 1000 to 499921.3% median hourly gap
- 1000 to 499917.6% median hourly gap
Positive gaps mean men were paid more; negative gaps mean women were paid more. These figures are employer-reported and describe the workforce distribution, not equal pay for the same job. The company link uses the exact Companies House number supplied by the service.
04 Supplier payments
Payment practices and performance
- Reporting period
- 1 December 2025 – 31 May 2026
- Filed
- 16 June 2026
- Shortest standard term
- 60 days
- Longest standard term
- Not supplied
- E-invoicing offered
- Yes
- Supply-chain finance
- Offered
- Payment codes
- No
- Construction retentions
- Reported as used
Complete reported payment fields
- Policy regime
- Regime-3
- Financial period started
- 1 December 2025
- Qualifying contracts
- Yes
- Payments made
- Yes
- Invoice value paid within 30 days
- £6,568,451
- Invoice value paid in 31–60 days
- £36,486,527
- Invoice value paid after 60 days
- £1,768,638
- Invoice value paid outside agreed terms
- £2,845,070
- Invoices paid in 31–60 days
- 78.0%
- Invoices unpaid due to dispute
- 0.0%
- Maximum contractual payment period
- 90 days
- Supplier-list charging policy
- No
- Supplier-list charges made
- No
Retention circumstances
Retention clauses are included only in qualifying construction contracts with suppliers in specific circumstances, if a specific project duration, a specific type of construction work and/or high value project sums
Retention release
Release mechanism aligned to JCT terms
Retention release stages
Before Practical Completion, full retention applied
After Practical Completion, retention reduces to 50%
Remaining retention released after Notice of Completion of Making Good (defects rectified)
Release mechanism aligned to JCT terms
- Retention in all contracts
- No
- Retention in standard terms
- No
- Retention threshold
- £185,000
- Standard retention rate
- 3.0%
- Retention compared with client
- 0.0%
- Retention compared with payments
- 2.0%
Reported terms and dispute process
- Standard payment terms
Qualifying contracts with entities: 60 days or the next payment run thereafter
No payment terms in majority of qualifying contracts with individuals
Purchase Order terms and conditions: the later of 60 calendar days and the next processing run immediately thereafter - Dispute resolution process
Pfizer offers suppliers the opportunity to check the current status of their invoices through an accounts payable portal. Suppliers can view when their invoice is due for payment on this portal. The tool is offered free of charge.
In case a supplier needs to contact Pfizer accounts payable department, an email address is available on every purchase order the supplier receives. Pfizer accounts payable department aims to resolve issues as promptly as possible, on average between 3 to 5 working days.
Earlier payment reports (11 shown)
- 38.0 average days to pay10.0% outside terms
- 40.0 average days to pay9.0% outside terms
- 34.0 average days to pay0.0% outside terms
- 37.0 average days to pay2.0% outside terms
- 39.0 average days to pay1.0% outside terms
- 39.0 average days to pay0.0% outside terms
- 38.0 average days to pay0.0% outside terms
- 40.0 average days to pay0.0% outside terms
- 35.0 average days to pay0.0% outside terms
- 43.0 average days to pay0.0% outside terms
- 55.0 average days to pay0.0% outside terms
This is a company-submitted statutory disclosure, not a credit rating. BritDB preserves the reporting period and links the report only through the Companies House number supplied by the official service. Percentages describe payments made during that period and may change in later reports.
05 Global legal identity
Legal Entity Identifier
PFIZER LIMITED
LEI 5493005D4SWG5IWHRB32 · jurisdiction GB
- Legal form
- H0PO
- Entity category
- GENERAL
- Entity created
- 27 November 1953
- Initial LEI registration
- 24 December 2013
- LEI last updated
- 27 March 2026
- Next renewal
- 4 April 2027
- Managing LOU
- 5493001KJTIIGC8Y1R12
- Legal address
- Ramsgate Road, Kent, Sandwich, CT13 9NJ, GB
- Headquarters address
- Ramsgate Road, Kent, Sandwich, CT13 9NJ, GB
GLEIF Level 2 relationships
IS ULTIMATELY CONSOLIDATED BY
From LEI 5493005D4SWG5IWHRB32 to LEI 765LHXWGK1KXCLTFYQ30
- Initial registration
- 4 September 2023
- Last updated
- 27 March 2026
- Next renewal
- 4 April 2027
- Validation sources
- ENTITY_SUPPLIED_ONLY
- Validation documents
- OTHER_OFFICIAL_DOCUMENTS
- Relationship periods
- Start: 2022-01-01T00:00:00.000Z; End: 2022-12-31T00:00:00.000Z; Type: ACCOUNTING_PERIOD; Start: 1953-11-28T00:00:00.000Z; Type: RELATIONSHIP_PERIOD; Start: 2021-01-01T00:00:00.000Z; End: 2021-12-31T00:00:00.000Z; Type: DOCUMENT_FILING_PERIOD
- Validation reference
- Not supplied
GLEIF parent-reporting exceptions
DIRECT ACCOUNTING CONSOLIDATION PARENT
NO_LEI
LEI data provides global legal identity and source-reported relationships, not a credit or regulatory approval. BritDB links Level 1 identities only through GLEIF’s Companies House registration-authority identifier and exact company number; Level 2 parent and fund relationships and reporting exceptions are reproduced as supplied by GLEIF.
06 Environmental regulation
Environment Agency records
PFIZER LIMITED
2490 · CT13 9NJ
- Permit or record holder
- PFIZER LIMITED
- Record date
- 27 July 2004
- Local authority
- Not supplied
- Regulated site or public record address
- RAMSGATE ROAD, SANDWICH, KENT, CT13 9NJ
- All populated source fields
- Action Number: 2490; Offender: PFIZER LIMITED; Address: RAMSGATE ROAD, SANDWICH, KENT, CT13 9NJ; Action Date: 2004-07-27
These are candidate company associations. The public-register downloads do not supply Companies House numbers. BritDB requires one unique exact holder-name and postcode match; the regulated site may differ from the registered office, so verify the record at source.
07 Public procurement
Contracts Finder awards
TERMS AND CONDITIONS FOR THE SUPPLY OF CENTRALLY PROCURED VACCINES
Business Energy and Industrial Strategy · ocds-b5fd17-f1e21aec-5568-46d5-a67d-3a3385a9fead
- Supplier named in award
- Pfizer Limited
- Award value
- £1
- Contract period
- 30 November 2021 – 31 December 2022
- Published
- 30 December 2021
- Procedure
- Single tender action (below threshold)
- Main CPV
- 33651600
- Source release ID
- ocds-b5fd17-f1e21aec-5568-46d5-a67d-3a3385a9fead-2021-12-30T10:18:48Z
Terms and Conditions for the Supply of Centrally Procured Vaccines - SARS-CoV-2 VACCINE SUPPLY AGREEMENT
Business Energy and Industrial Strategy · ocds-b5fd17-14ec1bca-9bba-4e69-b4d8-5ecfc80172dc
- Supplier named in award
- Pfizer Limited
- Award value
- £1
- Contract period
- 10 August 2021 – 31 December 2021
- Published
- 9 September 2021
- Procedure
- Single tender action (below threshold)
- Main CPV
- 33651600
- Source release ID
- ocds-b5fd17-14ec1bca-9bba-4e69-b4d8-5ecfc80172dc-2021-09-09T17:54:56+01:00
TERMS AND CONDITIONS FOR THE SUPPLY OF CENTRALLY PROCURED VACCINES
Business Energy and Industrial Strategy · ocds-b5fd17-0ff869a9-6ef6-46b2-9ce7-866eda4e60a8
- Supplier named in award
- Pfizer Limited
- Award value
- £1
- Contract period
- 7 June 2021 – 31 December 2021
- Published
- 6 July 2021
- Procedure
- Other - COVAX
- Main CPV
- 33651600
- Source release ID
- ocds-b5fd17-0ff869a9-6ef6-46b2-9ce7-866eda4e60a8-2021-07-06T21:58:11+01:00
Deed Of Amendment
Business Energy and Industrial Strategy · ocds-b5fd17-49259913-5850-47b9-946a-8459437b2de3
- Supplier named in award
- Pfizer Limited
- Award value
- £1
- Contract period
- 29 March 2021 – 31 December 2021
- Published
- 29 April 2021
- Procedure
- Single tender action (below threshold)
- Main CPV
- 33651600
- Source release ID
- ocds-b5fd17-49259913-5850-47b9-946a-8459437b2de3-2021-04-29T16:18:30+01:00
NHS Framework, North of England, Branded Medicines-Tranche A and Annual Tranche
NHS England · ocds-b5fd17-711f74f7-430c-4b80-a5e0-b3ce69f928b9
- Supplier named in award
- Pfizer Ltd
- Award value
- £1
- Contract period
- 1 March 2021 – 28 February 2023
- Published
- 13 May 2021
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-711f74f7-430c-4b80-a5e0-b3ce69f928b9-2021-05-13T10:21:38+01:00
Terms and Conditions for the Supply of Centrally Procured Vaccines - SARS-CoV-2 VACCINE SUPPLY AGREEMENT
Business Energy and Industrial Strategy · ocds-b5fd17-ea514197-f826-4ff4-a098-523542790f8e
- Supplier named in award
- Pfizer Limited
- Award value
- £1
- Contract period
- 13 October 2020 – 31 December 2021
- Published
- 10 December 2020
- Procedure
- Single tender action (below threshold)
- Main CPV
- 33651600
- Source release ID
- ocds-b5fd17-ea514197-f826-4ff4-a098-523542790f8e-2020-12-10T18:04:53Z
NHS Framework for the NHS London Region, Branded Medicines - Tranche A
NHS England · ocds-b5fd17-20ae12c6-3ba8-40bb-b423-51a2c2de6a67
- Supplier named in award
- Pfizer Ltd
- Award value
- £191,062,951
- Contract period
- 1 September 2020 – 31 August 2022
- Published
- 15 September 2020
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-20ae12c6-3ba8-40bb-b423-51a2c2de6a67-2020-09-15T14:26:04+01:00
Contract for the supply of stockpiled medicines
Department of Health and Social Care · ocds-b5fd17-cd4db7cd-e190-4d51-b38e-6623abcdf8ef
- Supplier named in award
- Pfizer Ltd
- Award value
- £5,680,769.73
- Contract period
- 17 June 2020 – 31 January 2021
- Published
- 3 July 2020
- Procedure
- Accelerated Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-cd4db7cd-e190-4d51-b38e-6623abcdf8ef-2020-07-03T15:00:05+01:00
NHS National Framework Agreement for the supply of products for the treatment of Haemophilia A
NHS England · ocds-b5fd17-1babd75c-bccc-4e92-ae60-e9319f60f432
- Supplier named in award
- Pfizer Ltd
- Award value
- £334,400,000
- Contract period
- 1 July 2020 – 30 June 2022
- Published
- 3 July 2020
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-1babd75c-bccc-4e92-ae60-e9319f60f432-2020-07-03T15:59:42+01:00
Contracts for the supply of Azithromycin & Dexamethasone products pt2
Department of Health and Social Care · ocds-b5fd17-15e59374-9657-49f6-9967-394f00bbe769
- Supplier named in award
- Pfizer Ltd
- Award value
- £2,108,686.32
- Contract period
- 11 May 2020 – 31 May 2020
- Published
- 18 June 2020
- Procedure
- Negotiated procedure without prior publication (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-15e59374-9657-49f6-9967-394f00bbe769-2020-06-18T15:14:53+01:00
NHS Framework Agreement - North of England - Tranche B
NHS England · ocds-b5fd17-2774d91d-05e7-400d-a217-4a5ca9db01ef
- Supplier named in award
- PFIZER LIMITED
- Award value
- £205,535,556
- Contract period
- 1 March 2020 – 28 February 2022
- Published
- 25 March 2020
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-2774d91d-05e7-400d-a217-4a5ca9db01ef-2020-03-25T08:39:13Z
NHS Midlands and East Branded Medicines - Tranche A
NHS England · ocds-b5fd17-1d021051-40c8-4883-ba04-47625826b7b8
- Supplier named in award
- Pfizer Ltd
- Award value
- £418,787,000
- Contract period
- 1 March 2020 – 28 February 2022
- Published
- 13 February 2020
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-1d021051-40c8-4883-ba04-47625826b7b8-2020-02-13T09:40:57Z
NHS South of England Branded Medicines - Tranche A - Contracts Finder Award Notice
NHS England · ocds-b5fd17-8b5e045d-6a03-4c26-b452-fcd5b23d5349
- Supplier named in award
- PFIZER LIMITED
- Award value
- £188,004,961
- Contract period
- 1 September 2019 – 31 August 2021
- Published
- 17 October 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-8b5e045d-6a03-4c26-b452-fcd5b23d5349-2019-10-17T10:16:17+01:00
NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity
NHS England · ocds-b5fd17-aaa2bd9e-0fdb-4884-8fca-b0d29a6ed15a
- Supplier named in award
- Pfizer Ltd
- Award value
- £251,930,337
- Contract period
- 1 September 2019 – 31 August 2020
- Published
- 1 October 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-aaa2bd9e-0fdb-4884-8fca-b0d29a6ed15a-2019-10-01T15:57:02+01:00
NHS Framework Agreement for Branded Medicines - National
NHS England · ocds-b5fd17-67d93048-4af9-4a0e-b313-bc852f01fca7
- Supplier named in award
- Pfizer Ltd
- Award value
- £1,351,341,890
- Contract period
- 1 May 2019 – 30 April 2021
- Published
- 9 August 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-67d93048-4af9-4a0e-b313-bc852f01fca7-2019-08-09T15:57:38+01:00
NHS Framework agreement for Branded Medicines - North of England - Tranche A
NHS England · ocds-b5fd17-2e43909f-31cc-4421-9f28-e9e4f18738ed
- Supplier named in award
- PFIZER LIMITED
- Award value
- £204,551,038
- Contract period
- 1 March 2019 – 28 February 2021
- Published
- 3 May 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-2e43909f-31cc-4421-9f28-e9e4f18738ed-2019-05-03T14:35:17+01:00
NHS England - Midlands and East Branded Medicines - Tranche B
NHS England · ocds-b5fd17-6c7a4e2c-58d3-4c41-8f77-dc419f83871c
- Supplier named in award
- Pfizer Ltd
- Award value
- £295,035,882
- Contract period
- 1 March 2019 – 28 March 2021
- Published
- 9 April 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-6c7a4e2c-58d3-4c41-8f77-dc419f83871c-2019-04-09T11:25:43+01:00
NHS England - Midlands and East Branded Medicines - Tranche B
NHS England · ocds-b5fd17-9878d09a-d11a-4940-a851-2b2b759217f2
- Supplier named in award
- Pfizer Ltd
- Award value
- £295,035,882
- Contract period
- 1 March 2019 – 28 March 2021
- Published
- 9 April 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-9878d09a-d11a-4940-a851-2b2b759217f2-2019-04-09T11:04:50+01:00
NHS England - Midlands and East Branded Medicines - Tranche B
NHS England · ocds-b5fd17-679e36df-b147-44d9-b0c1-53e4b91250c8
- Supplier named in award
- Pfizer Ltd
- Award value
- £295,035,882
- Contract period
- 1 March 2019 – 28 March 2021
- Published
- 9 April 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-679e36df-b147-44d9-b0c1-53e4b91250c8-2019-04-09T10:58:14+01:00
NHS England - Midlands and East Branded Medicines - Tranche B
NHS England · ocds-b5fd17-8aaddf75-dd22-4754-b241-885b44819814
- Supplier named in award
- Pfizer Ltd
- Award value
- £295,035,882
- Contract period
- 1 March 2019 – 28 March 2021
- Published
- 21 March 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-8aaddf75-dd22-4754-b241-885b44819814-2019-03-21T11:50:47Z
NHS England Framework Agreement: South of England (Tranche B)
NHS England · ocds-b5fd17-3dac71e6-cde5-406b-abc4-e91389859bf5
- Supplier named in award
- Pfizer Ltd
- Award value
- £501,400,000
- Contract period
- 1 September 2018 – 31 August 2020
- Published
- 1 October 2018
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-3dac71e6-cde5-406b-abc4-e91389859bf5-2018-10-01T08:55:31+01:00
Contract for the supply of meningococcal ACWY vaccine
DEPARTMENT OF HEALTH · ocds-b5fd17-0755a81e-bbd3-4d50-9c29-648cf82ee159
- Supplier named in award
- Pfizer Ltd
- Award value
- £0
- Contract period
- 1 June 2019 – 31 May 2023
- Published
- 5 January 2021
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33651600
- Source release ID
- ocds-b5fd17-0755a81e-bbd3-4d50-9c29-648cf82ee159-2021-01-05T16:17:10Z
NHS England Framework Agreement - London - Tranche A
NHS England · ocds-b5fd17-7b2dd479-3a52-442f-a080-4372505d9351
- Supplier named in award
- Pfizer Ltd
- Award value
- £211,435,404
- Contract period
- 1 September 2018 – 31 August 2020
- Published
- 7 November 2018
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-7b2dd479-3a52-442f-a080-4372505d9351-2018-11-07T09:28:44Z
The supplier link is exact, but the award remains buyer-published procurement data. BritDB requires the GB-COH identifier supplied in the Contracts Finder OCDS release and does not infer suppliers from similar names.
TM UK trade marks
Exact owner-name matches
NACLINEZ
Owner Pfizer Limited · classes 5
- Filed / designated
- 6 August 2014
- Valid until / renewal due
- 6 August 2024
NATLINEZ
Owner Pfizer Limited · classes 5
- Filed / designated
- 6 August 2014
- Valid until / renewal due
- 6 August 2024
XYPHIL
Owner Pfizer Limited · classes 5
- Filed / designated
- 25 February 2008
- Valid until / renewal due
- 25 February 2028
STIMUPHIL
Owner Pfizer Limited · classes 5
- Filed / designated
- 25 February 2008
- Valid until / renewal due
- 25 February 2028
DIFLUCAN ONE
Owner Pfizer Limited · classes 5
- Filed / designated
- 31 March 2000
- Valid until / renewal due
- 31 March 2020
Figurative mark
Owner Pfizer Limited · classes 5
- Filed / designated
- 13 February 1999
- Valid until / renewal due
- 13 February 2019
B Becket Pharmaceuticals
Owner Pfizer Limited · classes 5
- Filed / designated
- 17 October 1998
- Valid until / renewal due
- 17 October 2018
B Becket
Owner Pfizer Limited · classes 5
- Filed / designated
- 17 October 1998
- Valid until / renewal due
- 17 October 2018
B Becket
Owner Pfizer Limited · classes 5
- Filed / designated
- 17 October 1998
- Valid until / renewal due
- 17 October 2018
B Becket Pharmaceuticals
Owner Pfizer Limited · classes 5
- Filed / designated
- 17 October 1998
- Valid until / renewal due
- 17 October 2018
BECKET
Owner Pfizer Limited · classes 5
- Filed / designated
- 25 April 1998
- Valid until / renewal due
- 25 April 2018
BECKET PHARMACEUTICALS
Owner Pfizer Limited · classes 5
- Filed / designated
- 25 April 1998
- Valid until / renewal due
- 25 April 2018
CATHEDRAL
Owner Pfizer Limited · classes 5
- Filed / designated
- 25 April 1998
- Valid until / renewal due
- 25 April 2018
MINSTER PHARMACEUTICALS
Owner Pfizer Limited · classes 5
- Filed / designated
- 25 April 1998
- Valid until / renewal due
- 25 April 2018
CATHEDRAL PHARMACEUTICALS
Owner Pfizer Limited · classes 5
- Filed / designated
- 25 April 1998
- Valid until / renewal due
- 25 April 2018
MINSTER
Owner Pfizer Limited · classes 5
- Filed / designated
- 25 April 1998
- Valid until / renewal due
- 25 April 2018
RICHBOROUGH PHARMACEUTICALS
Owner Pfizer Limited · classes 5
- Filed / designated
- 13 July 1991
- Valid until / renewal due
- 13 July 2018
NIPENT
Owner Pfizer Limited · classes 5
- Filed / designated
- 12 June 1991
- Valid until / renewal due
- 12 June 2018
RICHBOROUGH
Owner Pfizer Limited · classes 5
- Filed / designated
- 23 May 1991
- Valid until / renewal due
- 23 May 2018
TOMUDEX
Owner Pfizer Limited · classes 5
- Filed / designated
- 18 March 1991
- Valid until / renewal due
- 18 March 2028
INVICTA PHARMACEUTICALS
Owner Pfizer Limited · classes 5
- Filed / designated
- 19 January 1989
- Valid until / renewal due
- 19 January 2026
NORVASC
Owner Pfizer Limited · classes 5
- Filed / designated
- 4 February 1988
- Valid until / renewal due
- 4 February 2025
DIFLUCAN
Owner Pfizer Limited · classes 5
- Filed / designated
- 18 July 1987
- Valid until / renewal due
- 18 July 2018
CARDURA
Owner Pfizer Limited · classes 5
- Filed / designated
- 4 May 1985
- Valid until / renewal due
- 4 May 2026
TROSYL
Owner Pfizer Limited · classes 5
- Filed / designated
- 19 July 1980
- Valid until / renewal due
- 19 July 2021
ISTIN
Owner Pfizer Limited · classes 5
- Filed / designated
- 5 September 1961
- Valid until / renewal due
- 5 September 2026
INVICTA
Owner Pfizer Limited · classes 1,2,3,4,6,17,18,19,20,21,22,26,30,31
- Filed / designated
- 18 July 1924
- Valid until / renewal due
- 18 July 2018
CHONDRO FRIENDLY
Owner Pfizer Limited · classes 5,35
- Filed / designated
- 27 June 2003
- Valid until / renewal due
- 27 June 2013
PFIZER CHONDRO FRIENDLY
Owner Pfizer Limited · classes 5,35
- Filed / designated
- 27 June 2003
- Valid until / renewal due
- 27 June 2013
SUPLEMIN
Owner Pfizer Limited · classes 5
- Filed / designated
- 3 December 2002
- Valid until / renewal due
- 3 December 2012
This is an exact normalised company-name match, not a registrar-confirmed ownership link. Another legal entity can have the same or a very similar name. UKIPO data is a historical 2018 snapshot; verify the owner and current status before relying on it.
08 Ownership and control
People with significant control
Pfizer Inc
- Owns 75% or more of shares
- Controls 75% or more of voting rights
- Legal authority
- General Corporation Law Of The State Of Delaware
- Legal form
- Corporation
- Notified
- 6 April 2017
PSC records are company-filed public-register information. When the exact same displayed individual name occurs at multiple companies, BritDB offers a non-indexed cross-reference page. It is a name match only, not proof that the records describe the same person. Service addresses and partial dates of birth are deliberately omitted.
09 Charity register
Charity Commission links
No exact company-number link in this snapshot
The Charity Commission extract did not explicitly associate this Companies House number with a charity. BritDB does not use a name-only match to fill the gap.
This company-level check covers the Charity Commission for England and Wales. Links are accepted only when the official extract supplies this exact company registration number. Scottish charities now have separate OSCR profiles, but OSCR’s bulk fields do not provide a Companies House number, so BritDB does not infer a company link.
10 Northern Ireland charity register
CCNI exact company links
No unambiguous company-number link found
The CCNI source number did not resolve uniquely to this Companies House record. BritDB did not use a name or address match.
CCNI publishes company numbers without a jurisdiction prefix. BritDB links only when the plausible padded UK and NI candidates resolve to exactly one Companies House company.
11 Sanctions screening
UK Sanctions List
No exact business-registration-number link found
The imported UK Sanctions List did not supply this Companies House number as a UK-linked business identifier. BritDB did not attempt a name-only match.
No exact link is not sanctions clearance. UK restrictions can apply through ownership or control even where an entity is not separately named. Always use the current official list and obtain appropriate advice for a legally significant decision.
12 Public procurement
Find a Tender links
Generic, Branded Generic & Proprietary Medicinal Products - Group 18
Regional Business Services Organisation, Procurement and Logistics Service · updated 3 July 2026
- Tender value
- £1,800,000,000
- Awards
- 214
LSL/MED/0228 Supply of Pfizer Pharmaceutical Products
LEIDOS SUPPLY, LIMITED · updated 28 May 2026
- Tender value
- Not supplied
- Awards
- 1
NHS National Framework for Generics Housekeeping
NHS England · updated 22 December 2025
- Tender value
- £52,023,284
- Awards
- 2
NHS National Framework for Transition products (Axitinib and Eltrombopag)
NHS England · updated 4 September 2025
- Tender value
- £80,909,200
- Awards
- 1
These links use only the GB-COH identifier supplied in the procurement record. A company may have other public-sector work that is absent, older, below publication thresholds or published without a Companies House identifier.
13 Environmental register
Environment Agency waste registrations
No exact company-number registration linked
The licensed Environment Agency subset did not contain this exact Companies House number. BritDB did not attempt a name-only match.
This is a privacy-reduced, exact-company subset. The full official register also includes sole traders and applicants without a matching Companies House number. Check the current Environment Agency register before relying on registration status.
14 Nature of business
Standard Industrial Classification
Other research and experimental development on natural sciences and engineering
15 Connected public record
Checks beyond the company register
Charity Commission
0 exact company-number links.
Northern Ireland charities
0 unambiguous company-number links.
Public contracts
4 procurement processes linked by exact GB-COH identifier.
Waste register
0 exact company-number registrations.
Corporate notices
The Gazette is not yet connected.
UK Sanctions List
No exact business-registration-number link in this report.
A checked source with no exact link is not a clean bill of health. Unchecked sources remain unknown, while sanctions may also apply through ownership or control of a listed person or entity.
16 Record timeline
Dates in the bulk record
- Detected change
Accounts due date: 2026-08-31 → 2027-08-31
- Confirmation statement
Latest confirmation statement made up to this date
- Accounts
Latest accounts made up to this date
- Incorporation
Company incorporated
17 Provenance
Sources for this profile
Identity, address, status, dates, SIC, previous names and mortgage totals.
Annual employer reports linked by the exact source-supplied Companies House number.
Statutory supplier-payment reports linked by the exact source-supplied Companies House number.
Global legal identities linked through Companies House registration authority RA000585.
Candidate permit and enforcement associations based on a unique exact holder-name and postcode match.
Historic awards linked by exact source-supplied GB-COH company identifier.
Current and ceased significant-control records joined by exact company number.
Daily England and Wales extract matched only by the official company registration number.
Daily CCNI export with company links only where the source number resolves unambiguously.
Complete FCDO list checked by exact UK-linked business registration number.
Procurement parties checked only through exact GB-COH identifiers.
Licensed subset linked only by exact Companies House number.
Financial regulation and licences.
Companies House, Charity Commission, OSCR and UK Sanctions List information is public-register data. BritDB reproduces and organises it with source-specific limits; official external links are kept on the dedicated source pages.